These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34181873)

  • 1. Protective effects of L-carnitine on behavioral alterations and neuroinflammation in striatum of glutaryl-COA dehydrogenase deficient mice.
    Guerreiro G; Faverzani J; Moura AP; Volfart V; Gome Dos Reis B; Sitta A; Gonzalez EA; de Lima Rosa G; Coitinho AS; Baldo G; Wajner M; Vargas CR
    Arch Biochem Biophys; 2021 Sep; 709():108970. PubMed ID: 34181873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. l-Carnitine prevents oxidative stress in striatum of glutaryl-CoA dehydrogenase deficient mice submitted to lysine overload.
    Guerreiro G; Amaral AU; Ribeiro RT; Faverzani J; Groehs AC; Sitta A; Deon M; Wajner M; Vargas CR
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2420-2427. PubMed ID: 31181292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of Neuroinflammatory Response and Histopathological Alterations Caused by Quinolinic Acid Administration in the Striatum of Glutaryl-CoA Dehydrogenase Deficient Mice.
    Amaral AU; Seminotti B; da Silva JC; de Oliveira FH; Ribeiro RT; Vargas CR; Leipnitz G; Santamaría A; Souza DO; Wajner M
    Neurotox Res; 2018 Apr; 33(3):593-606. PubMed ID: 29235064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disturbance of the glutamatergic system by glutaric acid in striatum and cerebral cortex of glutaryl-CoA dehydrogenase-deficient knockout mice: possible implications for the neuropathology of glutaric acidemia type I.
    Busanello EN; Fernandes CG; Martell RV; Lobato VG; Goodman S; Woontner M; de Souza DO; Wajner M
    J Neurol Sci; 2014 Nov; 346(1-2):260-7. PubMed ID: 25241940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal neuronal death mediated by astrocytes from the Gcdh-/- mouse model of glutaric acidemia type I.
    Olivera-Bravo S; Ribeiro CA; Isasi E; Trías E; Leipnitz G; Díaz-Amarilla P; Woontner M; Beck C; Goodman SI; Souza D; Wajner M; Barbeito L
    Hum Mol Genet; 2015 Aug; 24(16):4504-15. PubMed ID: 25968119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disturbance of Mitochondrial Dynamics, Endoplasmic Reticulum-Mitochondria Crosstalk, Redox Homeostasis, and Inflammatory Response in the Brain of Glutaryl-CoA Dehydrogenase-Deficient Mice: Neuroprotective Effects of Bezafibrate.
    Seminotti B; Brondani M; Ribeiro RT; Leipnitz G; Wajner M
    Mol Neurobiol; 2022 Aug; 59(8):4839-4853. PubMed ID: 35639256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked reduction of Na(+), K(+)-ATPase and creatine kinase activities induced by acute lysine administration in glutaryl-CoA dehydrogenase deficient mice.
    Amaral AU; Cecatto C; Seminotti B; Zanatta Â; Fernandes CG; Busanello EN; Braga LM; Ribeiro CA; de Souza DO; Woontner M; Koeller DM; Goodman S; Wajner M
    Mol Genet Metab; 2012 Sep; 107(1-2):81-6. PubMed ID: 22578804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutaric acidemia type 1: Treatment and outcome of 168 patients over three decades.
    Strauss KA; Williams KB; Carson VJ; Poskitt L; Bowser LE; Young M; Robinson DL; Hendrickson C; Beiler K; Taylor CM; Haas-Givler B; Hailey J; Chopko S; Puffenberger EG; Brigatti KW; Miller F; Morton DH
    Mol Genet Metab; 2020 Nov; 131(3):325-340. PubMed ID: 33069577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated levels of BDNF and cathepsin-d as possible peripheral markers of neurodegeneration in plasma of patients with glutaric acidemia type I.
    Guerreiro G; Diaz Jaques CE; Wajner M; Vargas CR
    Int J Dev Neurosci; 2020 Feb; 80(1):42-49. PubMed ID: 31910296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated glutaric acid levels in Dhtkd1-/Gcdh- double knockout mice challenge our current understanding of lysine metabolism.
    Biagosch C; Ediga RD; Hensler SV; Faerberboeck M; Kuehn R; Wurst W; Meitinger T; Kölker S; Sauer S; Prokisch H
    Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2220-2228. PubMed ID: 28545977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental evidence that bioenergetics disruption is not mainly involved in the brain injury of glutaryl-CoA dehydrogenase deficient mice submitted to lysine overload.
    Amaral AU; Cecatto C; Seminotti B; Ribeiro CA; Lagranha VL; Pereira CC; de Oliveira FH; de Souza DG; Goodman S; Woontner M; Wajner M
    Brain Res; 2015 Sep; 1620():116-29. PubMed ID: 25998543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute lysine overload provokes marked striatum injury involving oxidative stress signaling pathways in glutaryl-CoA dehydrogenase deficient mice.
    Amaral AU; Seminotti B; da Silva JC; de Oliveira FH; Ribeiro RT; Leipnitz G; Souza DO; Wajner M
    Neurochem Int; 2019 Oct; 129():104467. PubMed ID: 31121257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of Na+, K+-ATPase activity and expression in cerebral cortex of glutaryl-CoA dehydrogenase deficient mice: a possible mechanism for brain injury in glutaric aciduria type I.
    Amaral AU; Seminotti B; Cecatto C; Fernandes CG; Busanello EN; Zanatta Â; Kist LW; Bogo MR; de Souza DO; Woontner M; Goodman S; Koeller DM; Wajner M
    Mol Genet Metab; 2012 Nov; 107(3):375-82. PubMed ID: 22999741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic modulation of cerebral L-lysine metabolism in a mouse model for glutaric aciduria type I.
    Sauer SW; Opp S; Hoffmann GF; Koeller DM; Okun JG; Kölker S
    Brain; 2011 Jan; 134(Pt 1):157-70. PubMed ID: 20923787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative damage in glutaric aciduria type I patients and the protective effects of l-carnitine treatment.
    Guerreiro G; Faverzani J; Jacques CED; Marchetti DP; Sitta A; de Moura Coelho D; Kayser A; Kok F; Athayde L; Manfredini V; Wajner M; Vargas CR
    J Cell Biochem; 2018 Dec; 119(12):10021-10032. PubMed ID: 30129250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of GABAergic system contributes to epileptogenesis in glutaric acidemia type I.
    Vendramin Pasquetti M; Meier L; Loureiro S; Ganzella M; Junges B; Barbieri Caus L; Umpierrez Amaral A; Koeller DM; Goodman S; Woontner M; Gomes de Souza DO; Wajner M; Calcagnotto ME
    Epilepsia; 2017 Oct; 58(10):1771-1781. PubMed ID: 28762469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifactorial modulation of susceptibility to l-lysine in an animal model of glutaric aciduria type I.
    Sauer SW; Opp S; Komatsuzaki S; Blank AE; Mittelbronn M; Burgard P; Koeller DM; Okun JG; Kölker S
    Biochim Biophys Acta; 2015 May; 1852(5):768-77. PubMed ID: 25558815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of brain damage in glutaric acidemia type I: Lessons from the genetic mice model.
    Wajner M; Amaral AU; Leipnitz G; Seminotti B
    Int J Dev Neurosci; 2019 Nov; 78():215-221. PubMed ID: 31125684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative Stress, Disrupted Energy Metabolism, and Altered Signaling Pathways in Glutaryl-CoA Dehydrogenase Knockout Mice: Potential Implications of Quinolinic Acid Toxicity in the Neuropathology of Glutaric Acidemia Type I.
    Seminotti B; Amaral AU; Ribeiro RT; Rodrigues MDN; Colín-González AL; Leipnitz G; Santamaría A; Wajner M
    Mol Neurobiol; 2016 Nov; 53(9):6459-6475. PubMed ID: 26607633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased susceptibility to quinolinic acid-induced seizures and long-term changes in brain oscillations in an animal model of glutaric acidemia type I.
    Barbieri Caus L; Pasquetti MV; Seminotti B; Woontner M; Wajner M; Calcagnotto ME
    J Neurosci Res; 2022 Apr; 100(4):992-1007. PubMed ID: 34713466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.